1h Free Analyst Time
The publisher has been monitoring the antacids market and it is poised to grow by $712.45 mn during 2022-2026 progressing at a CAGR of 3.37% during the forecast period. The report on the antacids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population, poor lifestyle patterns, and increasing use of Non-steroidal anti-inflammatory drugs (NSAIDs).
The antacids market analysis includes the type segment and geographic landscape.
The antacids market is segmented as below:
By Type
- Non-symmetric antacids
- Symmetric antacids
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing e-commerce market as one of the prime reasons driving the antacids market growth during the next few years. Also, increasing awareness of GERD and self-medication will lead to sizable demand in the market.
The report on antacids market covers the following areas:
- Antacids market sizing
- Antacids market forecast
- Antacids market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antacids market vendors that include Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co. Also, the antacids market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2. Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3. Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4. Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5. Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Non-symmetric antacids - Market size and forecast 2021-2026
Exhibit 28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
5.4 Symmetric antacids - Market size and forecast 2021-2026
Exhibit 32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)
6. Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Brazil - Market size and forecast 2021-2026
Exhibit 74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9. Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10. Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 AmerisourceBergen Corp.
Exhibit 85: AmerisourceBergen Corp. - Overview
Exhibit 86: AmerisourceBergen Corp. - Business segments
Exhibit 87: AmerisourceBergen Corp. - Key offerings
Exhibit 88: AmerisourceBergen Corp. - Segment focus
10.4 Bayer AG
Exhibit 89: Bayer AG - Overview
Exhibit 90: Bayer AG - Business segments
Exhibit 91: Bayer AG - Key offerings
Exhibit 92: Bayer AG - Segment focus
10.5 Cardinal Health Inc.
Exhibit 93: Cardinal Health Inc. - Overview
Exhibit 94: Cardinal Health Inc. - Business segments
Exhibit 95: Cardinal Health Inc. - Key news
Exhibit 96: Cardinal Health Inc. - Key offerings
Exhibit 97: Cardinal Health Inc. - Segment focus
10.6 GlaxoSmithKline Plc
Exhibit 98: GlaxoSmithKline Plc - Overview
Exhibit 99: GlaxoSmithKline Plc - Business segments
Exhibit 100: GlaxoSmithKline Plc - Key news
Exhibit 101: GlaxoSmithKline Plc - Key offerings
Exhibit 102: GlaxoSmithKline Plc - Segment focus
10.7 Humco Holding Group Inc.
Exhibit 103: Humco Holding Group Inc. - Overview
Exhibit 104: Humco Holding Group Inc. - Product / Service
Exhibit 105: Humco Holding Group Inc. - Key offerings
10.8 Johnson and Johnson
Exhibit 106: Johnson and Johnson - Overview
Exhibit 107: Johnson and Johnson - Business segments
Exhibit 108: Johnson and Johnson - Key news
Exhibit 109: Johnson and Johnson - Key offerings
Exhibit 110: Johnson and Johnson - Segment focus
10.9 Novartis AG
Exhibit 111: Novartis AG - Overview
Exhibit 112: Novartis AG - Business segments
Exhibit 113: Novartis AG - Key offerings
Exhibit 114: Novartis AG - Segment focus
10.10 Sanofi SA
Exhibit 115: Sanofi SA - Overview
Exhibit 116: Sanofi SA - Business segments
Exhibit 117: Sanofi SA - Key news
Exhibit 118: Sanofi SA - Key offerings
Exhibit 119: Sanofi SA - Segment focus
10.11 Sun Pharmaceutical Industries Ltd.
Exhibit 120: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 121: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 122: Sun Pharmaceutical Industries Ltd. - Key offerings
10.12 WellSpring Pharmaceutical Corp.
Exhibit 123: WellSpring Pharmaceutical Corp. - Overview
Exhibit 124: WellSpring Pharmaceutical Corp. - Product / Service
Exhibit 125: WellSpring Pharmaceutical Corp. - Key offerings
11. Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Type - Market share 2021-2026 (%)
Exhibits 25: Data Table on Type - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Type
Exhibits 27: Data Table on Comparison by Type
Exhibits 28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Type ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: AmerisourceBergen Corp. - Overview
Exhibits 86: AmerisourceBergen Corp. - Business segments
Exhibits 87: AmerisourceBergen Corp. - Key offerings
Exhibits 88: AmerisourceBergen Corp. - Segment focus
Exhibits 89: Bayer AG - Overview
Exhibits 90: Bayer AG - Business segments
Exhibits 91: Bayer AG - Key offerings
Exhibits 92: Bayer AG - Segment focus
Exhibits 93: Cardinal Health Inc. - Overview
Exhibits 94: Cardinal Health Inc. - Business segments
Exhibits 95: Cardinal Health Inc. - Key news
Exhibits 96: Cardinal Health Inc. - Key offerings
Exhibits 97: Cardinal Health Inc. - Segment focus
Exhibits 98: GlaxoSmithKline Plc - Overview
Exhibits 99: GlaxoSmithKline Plc - Business segments
Exhibits 100: GlaxoSmithKline Plc - Key news
Exhibits 101: GlaxoSmithKline Plc - Key offerings
Exhibits 102: GlaxoSmithKline Plc - Segment focus
Exhibits 103: Humco Holding Group Inc. - Overview
Exhibits 104: Humco Holding Group Inc. - Product / Service
Exhibits 105: Humco Holding Group Inc. - Key offerings
Exhibits 106: Johnson and Johnson - Overview
Exhibits 107: Johnson and Johnson - Business segments
Exhibits 108: Johnson and Johnson - Key news
Exhibits 109: Johnson and Johnson - Key offerings
Exhibits 110: Johnson and Johnson - Segment focus
Exhibits 111: Novartis AG - Overview
Exhibits 112: Novartis AG - Business segments
Exhibits 113: Novartis AG - Key offerings
Exhibits 114: Novartis AG - Segment focus
Exhibits 115: Sanofi SA - Overview
Exhibits 116: Sanofi SA - Business segments
Exhibits 117: Sanofi SA - Key news
Exhibits 118: Sanofi SA - Key offerings
Exhibits 119: Sanofi SA - Segment focus
Exhibits 120: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 121: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 122: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 123: WellSpring Pharmaceutical Corp. - Overview
Exhibits 124: WellSpring Pharmaceutical Corp. - Product / Service
Exhibits 125: WellSpring Pharmaceutical Corp. - Key offerings
Exhibits 126: Inclusions checklist
Exhibits 127: Exclusions checklist
Exhibits 128: Currency conversion rates for US$
Exhibits 129: Research methodology
Exhibits 130: Validation techniques employed for market sizing
Exhibits 131: Information sources
Exhibits 132: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global antacids market: Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing e-commerce market.`
According to the report, one of the major drivers for this market is the rising geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advance Pharmaceutical Inc.
- AmerisourceBergen Corp.
- Bayer AG
- Cardinal Health Inc.
- GlaxoSmithKline Plc
- Humco Holding Group Inc.
- iNova Pharmaceuticals
- Johnson and Johnson
- Neogen Corp.
- Novartis AG
- NuCare Laboratories India
- Pfizer Inc.
- Pharmaceutical Associates Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- United Natural Foods Inc.
- WellSpring Pharmaceutical Corp.
- The Procter and Gamble Co.
